Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.
FDA establishment 3001236812, Valencia, California, United States. Part of TriMed's FDA records. Every inspection FDA has posted for the site, with its outcome and cited regulations and its recalls since 2016.
Inspections: 6
Official action indicated: 1
Warning letters: 1
Recalls since 2016: 10
Inspections by fiscal year
FY2018 to FY2027 to date; 0 classified OAI
How to read this
A hatched bar is a year that is not over, so its count covers only part of the year.
21 CFR 820.30(f). Design verification - documentation The design verification results, including identification of the design, method(s), the date and the individual(s) performing the verification, were not adequately documented in the design history file.
21 CFR 820.100(b). Documentation Corrective and preventive action activities and/or results have not been adequately documented.
21 CFR 820.198(a). Lack of or inadequate complaint procedures Procedures for receiving, reviewing, and evaluating complaints by a formally designated unit have not been established.
21 CFR 820.30(a). Design control - no procedures Procedures for design control have not been established.
21 CFR 820.80(e). Documentation Acceptance activities were not adequately documented.
21 CFR 820.184. Lack of or inadequate DHR procedures Procedures for device history records have not been adequately established.
21 CFR 820.30(i). Design changes - Lack of or Inadequate Procedures Procedures for design change have not been adequately established.
21 CFR 820.30(g). Design Validation - Risk analysis not performed/inadequate Risk analysis is incomplete.
21 CFR 820.100(a). Lack of or inadequate procedures Procedures for corrective and preventive action have not been adequately established.
21 CFR 820.80(d). Lack of or inadequate final acceptance procedures Procedures for finished device acceptance have not been adequately established.
21 CFR 820.120. Lack of or inadequate procedures for labeling Procedures to control labeling activities have not been adequately established.
21 CFR 820.184. Lack of or inadequate DHR procedures Procedures for device history records have not been adequately established.
21 CFR 820.30(a). Design control - no procedures Procedures for design control have not been established.
21 CFR 820.40. Lack of procedures, or not maintained Document control procedures have not been established and maintained.
21 CFR 820.198(c). Investigation of device failures Complaints involving the possible failure of a device, labeling and packaging to meet any of its specifications were not investigated where necessary.
21 CFR 820.30(g). Design Validation - Risk analysis not performed/inadequate Risk analysis is incomplete.
21 CFR 803.50(a)(1). Report of Death or Serious Injury An MDR report was not submitted within 30 days of receiving or otherwise becoming aware of information that reasonably suggests that a marketed device may have caused or contributed to a death or serious injury.
21 CFR 820.198(a). Lack of or inadequate complaint procedures Procedures for receiving, reviewing, and evaluating complaints by a formally designated unit have not been adequately established.
21 CFR 820.70(i). Software validation for automated processes Software used as part of the quality system has not been validated for its intended use according to an established protocol.
21 CFR 803.50(a)(2). Individual Report of Malfunction An MDR report was not submitted within 30 days of receiving or otherwise becoming aware of information that reasonably suggests that a marketed device has malfunctioned and would be likely to cause or contribute to a death or serious injury if the malfunction were to recur.
21 CFR 820.80(d). Lack of or inadequate final acceptance procedures Procedures for finished device acceptance have not been established.
21 CFR 820.30(a). Design control - no procedures Procedures for design control have not been established.
21 CFR 820.184. Lack of or inadequate DHR procedures Procedures for device history records have not been adequately established.
21 CFR 820.90(a). Nonconforming product, Lack of or inadequate procedures Procedures have not been adequately established to control product that does not conform to specified requirements.
21 CFR 820.198(c). Investigation of device failures Complaints involving the possible failure of a device , labeling and packaging to meet any of its specifications were not reviewed , evaluated and investigated where necessary.
21 CFR 820.22. Quality audits - Lack of or inadequate procedures Procedures for quality audits have not been adequately established.
21 CFR 803.17. Lack of Written MDR Procedures Written MDR procedures have not been implemented.
21 CFR 820.100(a). Lack of or inadequate procedures Procedures for corrective and preventive action have not been adequately established.
21 CFR 806.20(a). Records not kept There is no record maintained of a correction or removal action that was not required to be reported to FDA.
21 CFR 820.140. Lack of or inadequate procedures for handling Procedures for product handling have not been adequately established.
21 CFR 820.30(g). Design Validation - Risk analysis not performed/inadequate Risk analysis is incomplete.
21 CFR 820.70(i). Software validation for automated processes Software used as part of the quality system has not been validated for its intended use according to an established protocol.
21 CFR 820.30(j). Design history file The design history file was not established.
21 CFR 820.198(c). Investigation of device failures Complaints involving the possible failure of a device, labeling, and packaging to meet any of its specifications were not reviewed, evaluated, and investigated where necessary.
21 CFR 820.72(a). Equipment control activity documentation Equipment calibrations have not been documented.
21 CFR 803.50(a)(2). Individual Report of Malfunction An MDR report was not submitted within 30 days of receiving or otherwise becoming aware of information that reasonably suggests that a marketed device has malfunctioned and would be likely to cause or contribute to a death or serious injury if the malfunction were to recur.
21 CFR 820.22. Quality Audits - defined intervals Quality audits were not performed at defined intervals to determine whether the quality system activities and results comply with quality system procedures.
Voluntary Action Indicated (VAI)
Warning letters
Letters naming this establishment; each opens the letter
An FEI (FDA Establishment Identifier) names one physical site. Inspections, outcomes and citations come from FDA's Data Dashboard; FDA posts citations only for some inspections. Recalls come from FDA's enforcement reports (iRES), one row per recall even when it covers many lots. A contract site can make products for many companies, so the company shown is the one FDA lists as the site's firm. Form 483 observations are read by Arca from the 483s FDA posts in its FOIA reading room, most of them scans: the first sentence of each observation, with redactions as FDA made them. FDA posts 483s for a minority of inspections.FDA Data Dashboard, warning letters and enforcement reports